CD274 and cancer: The PD-L1 on the surface of tumor cells binds to PD-L1 on cancer cells, and reduce the function of cytotoxic T lymphocyte (CTL), inhibit the anti-tumor function of T cells, and lead to immune escape in the effector phase of the cancer-immunity cycle (10).